Clare E Sansom
Overview
Explore the profile of Clare E Sansom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sansom C
Ecancermedicalscience
. 2014 Dec;
8:483.
PMID: 25525461
The ninth conference of the International Institute for Anticancer Research, held in Sithonia, Greece in October 2014, included over 700 abstracts presented in 79 separate sessions and featured a wide...
2.
Shepherd A, Skelton S, Sansom C, Gomez K, Moss D, Hart D
Br J Haematol
. 2014 Sep;
168(3):413-20.
PMID: 25244644
Over 500 missense F8 mutations have been reported to cause non-severe haemophilia A. Some F8 genotypes appear to confer a higher risk of inhibitor formation than others and individuals with...
3.
Halling-Brown M, Pappalardo F, Rapin N, Zhang P, Alemani D, Emerson A, et al.
Philos Trans A Math Phys Eng Sci
. 2010 May;
368(1920):2799-815.
PMID: 20439274
The ultimate aim of the EU-funded ImmunoGrid project is to develop a natural-scale model of the human immune system-that is, one that reflects both the diversity and the relative proportions...
4.
Halling-Brown M, Shaban R, Frampton D, Sansom C, Davies M, Flower D, et al.
Mol Immunol
. 2009 Jun;
46(13):2699-705.
PMID: 19560824
T cell activation is the final step in a complex pathway through which pathogen-derived peptide fragments can elicit an immune response. For it to occur, peptides must form stable complexes...
5.
Halling-Brown M, Moss D, Sansom C, Shepherd A
Philos Trans A Math Phys Eng Sci
. 2009 Jun;
367(1898):2705-16.
PMID: 19487206
We have developed a computational Grid that enables us to exploit through a single interface a range of local, national and international resources. It insulates the user as far as...
6.
Halling-Brown M, Sansom C, Davies M, Titball R, Moss D
Trends Immunol
. 2008 Jul;
29(8):374-9.
PMID: 18603471
For many infectious diseases, protective immunity can be elicited by vaccination with pathogen-derived proteins. Peptides derived from these proteins are bound to major histocompatibility complex (MHC) molecules and presented to...
7.
Davies M, Lamikanra A, Sansom C, Flower D, Moss D, Travers P
Mol Immunol
. 2007 Sep;
45(4):1063-70.
PMID: 17870168
Human leukocyte antigen (HLA)-DM is a critical participant in antigen presentation that catalyzes the dissociation of the Class II-associated Invariant chain-derived Peptide (CLIP) from the major histocompatibility complex (MHC) Class...
8.
Davies M, Sansom C, Beazley C, Moss D
Mol Med
. 2004 Jun;
9(9-12):220-5.
PMID: 15208743
Antigenic peptide is presented to a T-cell receptor through the formation of a stable complex with a Major Histocompatibility Complex (MHC) molecule. Various predictive algorithms have been developed to estimate...